DDrare: Database of Drug Development for Rare Diseases

Liothyronine i 131 (DrugBank: Liothyronine, Liothyronine I 131)

2 diseases

ID	Disease name (Link within this page)	Number of trials
210	Single Ventricle	1
212	Tricuspid atresia	1

210. Single Ventricle [ 47 clinical trials, 54 drugs, (DrugBank: 23 drugs), 32 drug target genes, 66 drug target pathways]

Searched query = "Single Ventricle", "SV", "Single ventricle heart defect", "Univentricular heart", "UVH", "Single ventricular circulation syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 47 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00004828 (ClinicalTrials.gov)	December 1994	24/2/2000	Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure		Tricuspid Atresia;Heart Defects, Congenital	Drug: liothyronine I 131	FDA Office of Orphan Products Development	Children's Hospital and Health Center	Completed	N/A	17 Years	Both	28	Phase 1	NULL

212. Tricuspid atresia [ 6 clinical trials, 8 drugs, (DrugBank: 7 drugs), 8 drug target genes, 12 drug target pathways]

Searched query = "Tricuspid atresia", "TA"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 6 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00004828 (ClinicalTrials.gov)	December 1994	24/2/2000	Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure		Tricuspid Atresia;Heart Defects, Congenital	Drug: liothyronine I 131	FDA Office of Orphan Products Development	Children's Hospital and Health Center	Completed	N/A	17 Years	Both	28	Phase 1	NULL